University of Health Sciences,Gulhane School of Medicine

Ankara 06010

1 studies enrolling now · 2 studies all time

What they study most

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis

Studies at this site

• Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer — Recruiting now
• A Study of Imlunestrant, Investigator's Choice of Endocrine Therapy, and Imlunestrant Plus Abemaciclib in Participants With ER+, HER2- Advanced Breast Cancer — Running, not enrolling